These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 9216681)
1. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide. Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681 [TBL] [Abstract][Full Text] [Related]
2. Cell kill and cytostasis by ET-18-OCH3 and heat. Fujiwara K; Modest EJ; Wallen CA Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic interactions of heat and an ether lipid analogue in human ovarian carcinoma cells. Fujiwara K; Modest EJ; Welander CE; Wallen CA Cancer Res; 1989 Nov; 49(22):6285-9. PubMed ID: 2804975 [TBL] [Abstract][Full Text] [Related]
4. Change in the localization of heat shock protein 27 (HSP 27) in BG-1 human ovarian cancer cells following treatment by the ether lipid ET-18-OCH3. Fujiwara K; Shirafuji H; Fushitani K; Fujimoto K; Kohno I; Modest EJ Anticancer Res; 1999; 19(1A):181-7. PubMed ID: 10226541 [TBL] [Abstract][Full Text] [Related]
5. Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells. Kataoka S; Naito M; Tomida A; Tsuruo T Exp Cell Res; 1994 Nov; 215(1):199-205. PubMed ID: 7957669 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death. Shinomiya N; Shinomiya M; Wakiyama H; Katsura Y; Rokutanda M Exp Cell Res; 1994 Feb; 210(2):236-42. PubMed ID: 8299722 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of GnRH agonist in epithelial ovarian cancer. Kim JH; Park DC; Kim JW; Choi YK; Lew YO; Kim DH; Jung JK; Lim YA; Namkoong SE Gynecol Oncol; 1999 Aug; 74(2):170-80. PubMed ID: 10419728 [TBL] [Abstract][Full Text] [Related]
8. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Frankel A; Man S; Elliott P; Adams J; Kerbel RS Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766 [TBL] [Abstract][Full Text] [Related]
9. [Cancer chemo-endocrine therapy and its cell biological basis]. Nishiya I Hum Cell; 1998 Sep; 11(3):109-14. PubMed ID: 10086273 [TBL] [Abstract][Full Text] [Related]
10. Tumor cell kinetics following long-term treatment with antineoplastic ether phospholipids. Principe P; Sidoti C; Coulomb H; Broquet C; Braquet P Cancer Detect Prev; 1994; 18(5):393-400. PubMed ID: 7812986 [TBL] [Abstract][Full Text] [Related]
11. Activation of actin-cleavable interleukin 1beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Chen Z; Naito M; Mashima T; Tsuruo T Cancer Res; 1996 Nov; 56(22):5224-9. PubMed ID: 8912861 [TBL] [Abstract][Full Text] [Related]
12. Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells. Chapman RS; Chresta CM; Herberg AA; Beere HM; Heer S; Whetton AD; Hickman JA; Dive C Cytometry; 1995 Jul; 20(3):245-56. PubMed ID: 7587710 [TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line. Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826 [TBL] [Abstract][Full Text] [Related]
14. Tumor cell kinetics following antineoplastic ether phospholipid treatment. Principe P; Sidoti C; Braquet P Cancer Res; 1992 May; 52(9):2509-15. PubMed ID: 1568220 [TBL] [Abstract][Full Text] [Related]
15. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents. Stiewe T; Parssanedjad K; Esche H; Opalka B; Pützer BM Cancer Res; 2000 Jul; 60(14):3957-64. PubMed ID: 10919674 [TBL] [Abstract][Full Text] [Related]
16. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy. Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753 [TBL] [Abstract][Full Text] [Related]
17. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Chabot MC; Wykle RL; Modest EJ; Daniel LW Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333 [TBL] [Abstract][Full Text] [Related]
18. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin. O'Neill CF; Koberle B; Masters JR; Kelland LR Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies. Caserini C; Pratesi G; Tortoreto M; Bedogné B; Carenini N; Supino R; Perego P; Righetti SC; Zunino F Clin Cancer Res; 1997 Jun; 3(6):955-61. PubMed ID: 9815771 [TBL] [Abstract][Full Text] [Related]
20. [The relationship between morphological manifestations and cell kinetic changes of human lung cancer cells after exposure to chemotherapeutic agents]. Ito M Hokkaido Igaku Zasshi; 1986 Sep; 61(5):718-36. PubMed ID: 2430876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]